We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$19.6M
Cap. Flow
+$11.3M
Cap. Flow %
8.14%
Top 10 Hldgs %
36.55%
Holding
158
New
47
Increased
25
Reduced
35
Closed
29

Sector Composition

Rank Sector Weight
1 Energy 46.63%
2 Healthcare 18.69%
3 Technology 9.38%
4 Industrials 7.44%
5 Communication Services 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNET
1
DELISTED
RigNet, Inc.
RNET
$9.15M 6.6%
170,000
TCRT icon
2
Alaunos Therapeutics
TCRT
$4.74M
$7.2M 5.19%
11,903
-3,230
-21% -$1.8M
ET icon
3
Energy Transfer Partners
ET
$70.1B
$6.87M 4.95%
233,000
+60,600
+35% +$1.53M
WMB icon
4
Williams Companies
WMB
$90.5B
$4.81M 3.47%
82,700
+39,700
+92% +$1.84M
PGEN icon
5
Precigen
PGEN
$1.93B
$4.58M 3.3%
190,694
+142,286
+294% +$2.88M
OKE icon
6
Oneok
OKE
$58.7B
$4.34M 3.13%
63,700
+26,700
+72% +$1.69M
MMP
7
DELISTED
Magellan Midstream Partners, L.P.
MMP
$3.98M 2.87%
47,368
-14,400
-23% -$1.13M
EPD icon
8
Enterprise Products Partners
EPD
$83.8B
$3.81M 2.75%
97,360
-17,200
-15% -$634K
PAGP icon
9
Plains GP Holdings
PAGP
$5.23B
$3.1M 2.24%
36,376
+20,916
+135% +$1.58M
WES icon
10
Western Midstream Partners
WES
$19.6B
$2.82M 2.04%
45,000
+18,500
+70% +$962K
WWAV
11
DELISTED
The WhiteWave Foods Company
WWAV
$2.82M 2.03%
87,000
GNMX
12
DELISTED
Aevi Genomic Medicine Inc
GNMX
$2.64M 1.91%
340,000
HALO icon
13
Halozyme
HALO
$9.72B
$2.54M 1.83%
257,000
-93,500
-27% -$793K
BPL
14
DELISTED
Buckeye Partners, L.P.
BPL
$2.43M 1.75%
29,260
-3,000
-9% -$234K
PAA icon
15
Plains All American Pipeline
PAA
$17.4B
$2.22M 1.6%
37,000
-7,000
-16% -$398K
LNG icon
16
Cheniere Energy
LNG
$56.5B
$2.15M 1.55%
30,000
ENLC
17
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$2.15M 1.55%
51,500
+39,500
+329% +$1.51M
META icon
18
Meta Platforms (Facebook)
META
$1.51T
$2.03M 1.47%
30,200
-10,000
-25% -$615K
CEMP
19
DELISTED
Cempra, Inc.
CEMP
$1.97M 1.42%
184,000
+2,000
+1% +$19.3K
EPB
20
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
$1.8M 1.3%
49,570
+2,400
+5% +$80.3K
AHD
21
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
$1.63M 1.18%
+36,350
New +$1.63M
UNP icon
22
Union Pacific
UNP
$182B
$1.6M 1.15%
16,000
+8,000
+100% +$775K
TRN icon
23
Trinity Industries
TRN
$2.97B
$1.4M 1.01%
44,448
RGP
24
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$1.4M 1.01%
43,368
-6,800
-14% -$192K
TRGP icon
25
Targa Resources
TRGP
$60.4B
$1.4M 1.01%
+10,000
New +$1.15M

Similar funds

Belmont Global Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Belmont Global Advisors held 158 positions worth $139M, up 16% from $119M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Belmont Global Advisors deployed $11.3M of net new capital in Q2 2014, opening 47 new positions and adding to 25 existing holdings. Its largest new stake was ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE): 36,350 shares worth $1.63M.

By sector, the portfolio is most concentrated in Energy at 47% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alaunos Therapeutics, an estimated $1.8M trimmed.

  • Belmont Global Advisors's largest Q2 2014 buy was ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE): 36,350 shares worth $1.63M.
  • Belmont Global Advisors added most to Precigen in Q2 2014, an estimated $2.88M increase.
  • Belmont Global Advisors's biggest Q2 2014 reduction was Alaunos Therapeutics, cutting an estimated $1.8M.
  • Belmont Global Advisors fully exited KKR & Co in Q2 2014, selling an estimated $1.78M.
  • Belmont Global Advisors's ten largest holdings make up 37% of its $139M portfolio in Q2 2014.
  • Belmont Global Advisors opened 47 new positions and closed 29 in Q2 2014.
  • Belmont Global Advisors's portfolio value rose 16% quarter-over-quarter to $139M.

Based on Belmont Global Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.